FDA's Pediatric Advisory Committee will weigh the safety and benefits of using opioid products to treat cough in children as part of a two-day meeting next month that will also include discussion on whether several other drugs and devices can safely be used for children. FDA Commissioner Scott Gottlieb said Monday (Aug. 21) that the independent panel’s review will help guide the agency in its decisions regarding the products. On the first day of the meeting, Sept. 11, the committee...